Skip to content

    Cold, Flu, & Cough Health Center

    Font Size
    A
    A
    A

    Does Tamiflu Work? Questions Continue

    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Nov. 14, 2012 -- Does the blockbuster flu drug Tamiflu really work?

    Nobody knows for sure, claims the prestigious Cochrane Collaboration, a group that issues careful analyses of the evidence behind drugs and vaccines. Cochrane researchers say there's not enough evidence to prove Tamiflu works.

    The CDC and the World Health Organization recommend the drug as effective. The FDA and the European Medicines Agency approve Tamiflu for the treatment and prevention of flu.

    Tamiflu can lessen symptoms and make flu illness one to two days shorter, the CDC says. It can also help prevent flu illness in people who have come into close contact with a flu patient.

    But it’s not a cure-all, says pediatric infectious disease specialist Marcelo Laufer, MD, of Miami Children's Hospital.

    "One of the problems is that Tamiflu is seen by the public as a drug that will save you from all cases of the flu," he says. "Tamiflu can decrease the duration of illness by 30% to 40%, and decrease flu severity by about 40% -- but only if taken in the first 36 to 48 hours of illness. And you know that will not happen all the time."

    Request for More Data

    Cochrane researchers, joined by the BMJ (formerly the British Medical Journal), complained that Tamiflu maker Roche is keeping important data from the public. They note that despite requests dating back to 2009, Roche refuses to release crucial data from eight of 10 Tamiflu clinical trials.

    "This means that taxpayers in the United Kingdom and around the world have spent billions of dollars stockpiling a drug for which no one except the manufacturer has seen the complete evidence base," Fiona Godlee, BMJ editor-in-chief, wrote in an editorial.

    In a letter sent this week to respected Oxford professor John Bell -- a Roche board member -- Godlee warned that too much Tamiflu data is being kept secret.

    "There are concerns on a number of fronts: the likely overstating of effectiveness and apparent under-reporting of potentially serious adverse effects," she wrote.

    The data in question is what researchers call "patient-level data" collected from each study participant in a clinical trial, with only identifying information removed.

    In a response to BMJ, Roche last month issued a statement saying it does not make the data available to protect patient confidentiality.

    "Roche provided the Cochrane group with access to 3,200 pages of very detailed information, enabling their questions to be answered," the statement says.

    Today on WebMD

    hot toddy
    15 tips to help you feel better.
    man sneezing into elbow
    Do echinacea and vitamin C really help a cold?
     
    teen girl coughing
    Get a good night’s rest with these remedies.
    elder berry
    Eat these to fight colds, flu, and more.
     
    Natural Cold Flu Remedies Slideshow
    Slideshow
    cold weather
    VIDEO
     
    Allergy And Sinus Symptom Evaluator
    Article
    Boy holding ear
    Slideshow
     
    woman receiving vaccine shot
    Article
    woman with fever
    Article
     
    Waking up from sleep
    Article
    woman with sore throat
    Slideshow